Company / Shareholders' Equity
Bionano Genomics, Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$44.4M
FY2025
5-year range
$35.4M / $337.1M
FY2021-FY2025
Trend
+25.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity returned to growth in FY2025 after 3 years of decline, reaching $44M.
Based on SEC 10-K filings.
$44M in FY2025 with a 5-year CAGR of +4.8%.
Declined from $96M to $44M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -43.7%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 25.6% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.4M | +25.6% |
| FY2024 | $35.4M | -63.2% |
| FY2023 | $96.2M | -61.4% |
| FY2022 | $249.4M | -26.0% |
| FY2021 | $337.1M | +860.9% |
| FY2020 | $35.1M | +871.0% |
| FY2019 | $3.6M | -64.4% |
| FY2018 | $10.1M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026